Abstract:STUDY HYPOTHESIS: Detailed structural comparisons of sperm-specific glyceraldehyde 3-phosphate dehydrogenase, spermatogenic (GAPDHS) and the somatic glyceraldehyde 3-phosphate dehydrogenase (GAPDH) isozyme should facilitate the identification of selective GAPDHS inhibitors for contraceptive development.STUDY FINDING: This study identified a small-molecule GAPDHS inhibitor with micromolar potency and >10-fold selectivity that exerts the expected inhibitory effects on sperm glycolysis and motility.WHAT IS KNOWN ALREADY: Glycolytic ATP production is required for sperm motility and male fertility in many mammalian species. Selective inhibition of GAPDHS, one of the glycolytic isozymes with restricted expression during spermatogenesis, is a potential strategy for the development of a non-hormonal contraceptive that directly blocks sperm function.STUDY DESIGN, SAMPLES/MATERIALS, METHODS: Homology modeling and x-ray crystallography were used to identify structural features that are conserved in GAPDHS orthologs in mouse and human sperm, but distinct from the GAPDH orthologs present in somatic tissues. We identified three binding pockets surrounding the substrate and cofactor in these isozymes and conducted a virtual screen to identify small molecule compounds predicted to bind more tightly to GAPDHS than to GAPDH. Following the production of recombinant human and mouse GAPDHS, candidate compounds were tested in dose-response enzyme assays to identify inhibitors that blocked the activity of GAPDHS more effectively than GAPDH. The effects of a selective inhibitor on the motility of mouse and human sperm were monitored by computer-assisted sperm analysis, and sperm lactate production was measured to assess inhibition of glycolysis in the target cell.MAIN RESULTS AND THE ROLE OF CHANCE: Our studies produced the first apoenzyme crystal structures for human and mouse GAPDHS and a 1.73 angstrom crystal structure for NAD+-bound human GAPDHS, facilitating the identification of unique structural features of this sperm isozyme. In dose-response assays T0501_7749 inhibited human GAPDHS with an IC50 of 1.2 mu M compared with an IC50 of 38.5 mu M for the somatic isozyme. This compound caused significant reductions in mouse sperm lactate production (P = 0.017 for 100 mu M T0501_7749 versus control) and in the percentage of motile mouse and human sperm (P values from <0.05 to <0.0001, depending on incubation conditions).LIMITATIONS, REASONS FOR CAUTION: The chemical properties of T0501_7749, including limited solubility and nonspecific protein binding, are not optimal for drug development.WIDER IMPLICATIONS OF THE FINDINGS: This study provides proof-of-principle evidence that GAPDHS can be selectively inhibited, causing significant reductions in sperm glycolysis and motility. These results highlight the utility of structure-based drug design and support further exploration of GAPDHS, and perhaps other sperm-specific isozymes in the glycolytic pathway, as contraceptive targets.LARGE SCALE DATA: None. Coordinates and data files for three GAPDHS crystal structures were deposited in the RCSB Protein Data Bank (http://www.rcsb.org).

Localization and expression analysis of sperm‐specific glyceraldehyde 3‐phosphate dehydrogenase in bull spermatozoa with contrasting sperm motility

Sorted Bulls' X-Chromosome-Bearing Spermatozoa Show Increased GAPDHS Activity Correlating with Motility

Low Sperm Motility Is Determined by Abnormal Protein Modification during Epididymal Maturation

Gene Expression and Protein Synthesis in Mitochondria Enhance the Duration of High-Speed Linear Motility in Boar Sperm

The role of sperm-specific glyceraldehyde-3-phosphate dehydrogenase in the development of pathologies—from asthenozoospermia to carcinogenesis

Candidates for Reproductive Biomarkers: Protein Phosphorylation and Acetylation Positively Related to Selected Parameters of Boar Spermatozoa Quality.

Integrating sperm cell transcriptome and seminal plasma metabolome to analyze the molecular regulatory mechanism of sperm motility in Holstein stud bulls

Protein profiling of testicular tissue from boars with different levels of hyperactive sperm motility

Proteomics Analysis of Asthenozoospermia and Identification of Glucose-6-phosphate Isomerase As an Important Enzyme for Sperm Motility.

Retained Acetylated Histone Four in Bull Sperm Associated With Fertility

Comparative Proteomic Analyses of Poorly Motile Swamp Buffalo Spermatozoa Reveal Low Energy Metabolism and Deficiencies in Motility-Related Proteins.

Amino Acids of Seminal Plasma Associated With Freezability of Bull Sperm

Structural Analyses to Identify Selective Inhibitors of Glyceraldehyde 3-Phosphate Dehydrogenase-S, a Sperm-Specific Glycolytic Enzyme

Sperm Function, Protein Phosphorylation, and Metabolism Differ in Mice Lacking Successive Sperm-Specific Glycolytic Enzymes†

Sperm proteins ODF2 and PAWP as markers of fertility in breeding bulls

The expression of the new epididymal luminal protein of PDZ domain containing 1 is decreased in asthenozoospermia.

Proteomic analysis of good- and poor-quality human sperm demonstrates that several proteins are routinely aberrantly regulated

High-throughput proteomic characterization of seminal plasma from bulls with contrasting semen quality

Lysine Glutarylation in Human Sperm is Associated with Progressive Motility

Single-center thorough evaluation and targeted treatment of globozoospermic men

Complexity and modification of the bull sperm glycocalyx during epididymal maturation